Inhibition of hepatitis B virus and induction of hepatoma cell apoptosis by ASGPR-directed delivery of shRNAs.
Hepatitis B virus (HBV) infection is a worldwide liver disease and nearly 25% of chronic HBV infections terminate in hepatocellular carcinoma (HCC). Currently, there is no effective therapy to inhibit HBV replication and to eliminate hepatoma cells, making it highly desired to develop novel therapie...
Main Authors: | Jingwei Ma, Chunmei Huang, Xinxin Yao, Chuan Shi, Lifang Sun, Lu Yuan, Ping Lei, Huifen Zhu, Hongbo Liu, Xiongwen Wu, Qin Ning, Chun Zhou, Guanxin Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3477153?pdf=render |
Similar Items
-
Comparing the silencing efficacy of dicer-independent and dependent shRNAs
by: Nhlabatsi, Neliswa
Published: (2015) -
Towards Antiviral shRNAs Based on the AgoshRNA Design.
by: Ying Poi Liu, et al.
Published: (2015-01-01) -
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
by: Md. Emranul Karim, et al.
Published: (2018-05-01) -
96 shRNAs designed for maximal coverage of HIV-1 variants
by: Shen Sylvie, et al.
Published: (2009-06-01) -
In vitro Inhibition of Border Disease Virus Replication With Lentivirus-Mediated shRNAs
by: Mohammad Javad Hajihasani Arani, et al.
Published: (2021-08-01)